Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Sickle Cell Disease (Pediatrics)

Management of Vaso-Occlusive Crisis and Acute Chest Syndrome—Pain Management

What is the best pharmacologic treatment for sickle cell disease pain crises?

Baker M, Hafner JW.

Source‎: Ann Emerg Med 2012;59(6):515-6.

Indexed‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate.

Frei-Jones MJ, Field JJ, DeBaun MR.

Source‎: Pediatr Blood Cancer 2009;53(3):401-5.

Indexed‎: PubMed 19422031

DOI‎: 10.1002/pbc.22048

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial.

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Source‎: Thromb Haemost 2007;98(2):392-6.

Indexed‎: PubMed 17721622

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.